ARCHIVES

Study Tests PARP Inhibitor ABT-888 For Several Cancers

This article is from The Cancer Letter archive.

Vol. 32 No. 9 | September 25, 2009

Download PDF Visit The Full Archive

Related Articles

Funding NCI Bypass Budget The “Very Least” Congress Could Do, Congressman Durbin Says

July 13, 1990

NCI Tests Early Phase Study To Hasten Drug Development

August 31, 2007

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

July 29, 2011

In Brief: DOE honors radiation Therapy Pioneers; Center Honors Nixon, Lansing, Coffey

June 20, 1997

DOD Names Innovator Award Recipients.

April 26, 2002

Fountain Hearings Turn Up Some Responsible Criticism, some Not, Much Support for Program

June 24, 1977